⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17042948 | 1.00 | — | — | |
| SCHEMBL17042949 | 1.00 | — | — | |
| SCHEMBL17047993 | 1.00 | — | — | |
| SCHEMBL17043001 | 1.00 | — | — | |
| SCHEMBL17042046 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3609098 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL3607849 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL3607842 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL3607844 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL3609103 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230406851-A1 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GB) | 2023-12-21 | — | — | US | disclosed |
| WO-2023122945-A1 | CYCLIC POLYPEPTIDE COMPOUNDS AND USES THEREOF | 知和(山东)大药厂有限公司 | 2023-07-06 | — | — | WO | disclosed |
| EP-3998267-A1 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | Bellus Health Cough Inc. (CA) | 2022-05-18 | — | — | EP | disclosed |
| US-20220062290-A1 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GB) | 2022-03-03 | — | — | US | disclosed |
| US-20220062290-A1 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GB) | 2022-03-03 | — | — | US | disclosed |
| EP-3381917-B1 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | BELLUS HEALTH COUGH INC (CA) | 2021-09-08 | — | — | EP | disclosed |
| EP-3381917-B1 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | BELLUS HEALTH COUGH INC (CA) | 2021-09-08 | — | — | EP | disclosed |
| US-20210228588-A1 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GB) | 2021-07-29 | — | — | US | disclosed |
| US-20210228588-A1 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GB) | 2021-07-29 | — | — | US | disclosed |
| CN-107485612-B | Imidazopyridine compounds and uses thereof | 尼奥迈德研究所 | 2021-03-30 | — | — | CN | disclosed |
| US-8357709-B2 | 2,4-disubstituted pyrrolidine orexin receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2013-01-22 | — | — | US | disclosed |
| US-20110201652-A1 | 2,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists | MERCK SHARP & DOHME LLC | 2011-08-18 | — | — | US | disclosed |
| US-20110201652-A1 | 2,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists | MERCK SHARP & DOHME LLC | 2011-08-18 | — | — | US | disclosed |
| US-20110201652-A1 | 2,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists | MERCK SHARP & DOHME LLC | 2011-08-18 | — | — | US | disclosed |
| EP-2348856-A1 | 2,4-DISUBSTITUTED PYRROLIDINE OREXIN RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010048014-A1 | 2,4-DISUBSTITUTED PYRROLIDINE OREXIN RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2010-04-29 | — | — | WO | disclosed |
| WO-2010048014-A1 | 2,4-DISUBSTITUTED PYRROLIDINE OREXIN RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2010-04-29 | — | — | WO | disclosed |
| US-7649001-B2 | Fused benzene derivative and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-01-19 | — | — | US | disclosed |
| US-20090042857-A1 | Novel Pharmaceutical | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-02-12 | — | — | US | disclosed |
| EP-1987827-A1 | NOVEL PHARMACEUTICAL | Takeda Pharmaceutical Company Limited (JP) | 2008-11-05 | — | — | EP | disclosed |